Broadfin Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$2.11M Sell
89,730
-8,507
-9% -$200K 0.28% 33
2019
Q3
$1.82M Sell
98,237
-559,761
-85% -$10.4M 0.34% 35
2019
Q2
$12.2M Buy
657,998
+450,000
+216% +$8.37M 2.66% 12
2019
Q1
$5.08M Buy
207,998
+88,704
+74% +$2.17M 1.05% 30
2018
Q4
$3.09M Sell
119,294
-171,919
-59% -$4.46M 0.41% 38
2018
Q3
$9.22M Sell
291,213
-228,574
-44% -$7.23M 1.36% 22
2018
Q2
$20.2M Sell
519,787
-1,061,629
-67% -$41.2M 3.18% 11
2018
Q1
$43.6M Sell
1,581,416
-447,102
-22% -$12.3M 6.8% 3
2017
Q4
$36.7M Sell
2,028,518
-1,427,192
-41% -$25.8M 6% 3
2017
Q3
$55.8M Sell
3,455,710
-962,649
-22% -$15.5M 8.26% 1
2017
Q2
$61.2M Sell
4,418,359
-529,044
-11% -$7.33M 7.43% 1
2017
Q1
$74.2M Buy
4,947,403
+1,047,816
+27% +$15.7M 8.99% 2
2016
Q4
$51.1M Buy
3,899,587
+1,049,587
+37% +$13.7M 5.67% 4
2016
Q3
$49.1M Buy
2,850,000
+1,599,896
+128% +$27.6M 4.4% 7
2016
Q2
$22.6M Sell
1,250,104
-215,371
-15% -$3.89M 2.19% 10
2016
Q1
$27.8M Sell
1,465,475
-766,526
-34% -$14.6M 2.69% 9
2015
Q4
$59.6M Buy
2,232,001
+370,000
+20% +$9.88M 3.67% 4
2015
Q3
$45.4M Sell
1,862,001
-534,680
-22% -$13M 2.53% 7
2015
Q2
$74.7M Sell
2,396,681
-411,492
-15% -$12.8M 4.01% 3
2015
Q1
$40.9M Hold
2,808,173
3.18% 8
2014
Q4
$28.3M Hold
2,808,173
2.46% 11
2014
Q3
$23.4M Hold
2,808,173
2.45% 11
2014
Q2
$34.6M Buy
2,808,173
+575,000
+26% +$7.08M 3.37% 7
2014
Q1
$31.1M Buy
+2,233,173
New +$31.1M 3.01% 7